Overcoming the technical, logistical and translational challenges of delivering meaningful clinical efficacy with radionuclide therapies

Welcome to Targeted Radiopharmaceuticals (TRP) Summit, the industry-led forum designed to accelerate the development of next-generation radiopharmaceuticals. The faculty of expert speakers will lead us through a comprehensive discussion of the challenges & opportunities currently facing this space as it undergoes an exciting resurgence.

We have been working with companies including: Endocyte, MTR, Actinium Pharmaceuticals, Tagworks, Bayer & Roche, to assemble this agenda. The key focus of which will be exploring how to advance the therapeutic potential of radiation. The important role of diagnostic imaging is also key to providing a truly well-rounded conference in this field. As such, fully appreciating the potential that combinations of theranostics & diagnostics offer will be integral throughout.

The main areas of focus include:

  • Identifying & Assessing the Therapeutic Potential of Novel Targets
  • Updates on the New Regulatory Hurdles in the US & EU
  • Optimising Chemical Modification Methods & Combination Rationale - Radioimmunotherapy and Beyond

View full event guide for more information.

"Overall great conference with a combination of excellent speakers and focused, relevant content. A Good balance of technical and business driven talks."

Eisai, Past Hanson Wade Attendee

“I thought the conference was very focused. It was time well spent. I learned a lot and had productive networking sessions.”

Genentech, Past Hanson Wade Attendee

"A good meeting in terms of presentation topics, interactive workshop"

Celgene, Past Hanson Wade Attendee

Key Benefits of Attending:


Join the peer-led discussion into the critical issues behind the technical advancement of the next generation of radiopharmaceuticals


Gain key insights that will inform your steps forward through preclinical testing, translation and clinical trials


Hear how industry leaders are approaching the important logistical issues behind planning and executing radiopharmaceutical trials

Hear from Expert Speakers including:

Chris Leamon

Vice President of Research


Christiane Smerling

Head of Nuclear Medicine & Imaging

3B Pharmaceuticals

Cristina Müller

Research Group Leader at Paul Scherrer Institute and Private Docent

ETH Zurich

Dale Ludwig

Chief Scientific Officer

Actinium Pharmaceuticals

Urs Hagemann

Laboratory Head


Proud to Partner With:

Minerva Imaging